UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1)

Emerging infectious diseases, 2016-07, Vol.22 (7), p.1253-1256

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

Vaccine, 2013-06, Vol.31 (29), p.3025-3033

2013

Link zum Volltext

Verfügbarkeit prüfen

Phylogenetic Origin and Virulence Genotype in Relation to Resistance to Fluoroquinolones and/or Extended-Spectrum Cephalosporins and Cephamycins among Escherichia coli Isolates from Animals and Humans

The Journal of infectious diseases, 2003-09, Vol.188 (5), p.759-768

2003

Link zum Volltext

Verfügbarkeit prüfen

Research unit network (RUN) as a learning research system

Journal of clinical and translational science, 2023, Vol.7 (1), p.e89-e89, Article e89

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Risk for Readmission, Methicillin-Resistant Staphylococcus aureus (MRSA) Infection, and Death among MRSA-Colonized Veterans

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1169-1172

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

The Journal of infectious diseases, 2015-08, Vol.212 (4), p.552-561

2015

Link zum Volltext

Verfügbarkeit prüfen

High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial

Vaccine, 2020-05, Vol.38 (23), p.3934-3941

2020

Link zum Volltext

Verfügbarkeit prüfen

Strain-Relatedness of Methicillin- Resistant Staphylococcus aureus Isolates Recovered from Patients with Repeated Infection

Clinical infectious diseases, 2008-04, Vol.46 (8), p.1241-1247

2008

Link zum Volltext

Verfügbarkeit prüfen

BD Phoenix and Vitek 2 Detection of mecA-Mediated Resistance in Staphylococcus aureus with Cefoxitin

Journal of Clinical Microbiology, 2009-09, Vol.47 (9), p.2879-2882

2009

Link zum Volltext

Verfügbarkeit prüfen

Cathelicidin Peptides Inhibit Multiply Antibiotic-Resistant Pathogens from Patients with Cystic Fibrosis

Antimicrobial Agents and Chemotherapy, 2001-10, Vol.45 (10), p.2838-2844

2001

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan

Clinical pharmacokinetics, 2023, Vol.62 (1), p.127-139

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

Clinical infectious diseases, 2023-08, Vol.77 (4), p.560-564

2023

Link zum Volltext

Verfügbarkeit prüfen

CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination

Vaccine, 2017-07, Vol.35 (33), p.4255-4261

2017

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Nontypeable Haemophilus influenzae Phase-Variable Genes During Experimental Human Nasopharyngeal Colonization

The Journal of infectious diseases, 2013-09, Vol.208 (5), p.720-727

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

Vaccine, 2014-05, Vol.32 (23), p.2732

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II randomized, double-blinded comparison of a single high dose (5 × 108 TCID50 ) of modified vaccinia Ankara compared to a standard dose (1 × 108 TCID50 ) in healthy vaccinia-naïve individuals

Vaccine, 2014-05, Vol.32 (23), p.2732-2739

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunological Outcomes Following Human Inoculation With Nontypeable Haemophilus influenzae

The Journal of infectious diseases, 2013-09, Vol.208 (5), p.728-738

2013

Link zum Volltext

Verfügbarkeit prüfen

First Description of Klebsiella pneumoniae Harboring CTX-M β-Lactamases (CTX-M-14 and CTX-M-3) in Taiwan

Antimicrobial Agents and Chemotherapy, 2002-04, Vol.46 (4), p.1098-1100

2002

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone® ) administered by intradermal and intramuscular route in healthy adults

Vaccine, 2011-08, Vol.29 (34), p.5666-5674

2011

Link zum Volltext

Verfügbarkeit prüfen

Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial

Journal of lower genital tract disease, 2020-07, Vol.24 (3), p.277-283

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine

The Journal of infectious diseases, 2015-08, Vol.212 (4), p.525-530

2015

Link zum Volltext

Verfügbarkeit prüfen

Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan

Emerging infectious diseases, 2002-05, Vol.8 (5), p.522-524

2002

Link zum Volltext

Verfügbarkeit prüfen

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

The Journal of infectious diseases, 2016-10, Vol.214 (7), p.1020-1029

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(91)
Buchkapitel
(1)

Sprache

Englisch
(92)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(73)
Humans
(67)
Microbiology
(39)
Female
(38)
Immunology
(38)
Infectious Diseases
(36)
Male
(36)
Adult
(30)
Biological And Medical Sciences
(30)
Vaccines
(27)
Middle Aged
(24)
Fundamental And Applied Biological Sciences. Psychology
(22)
Young Adult
(20)
Medicine, Research & Experimental
(19)
Research & Experimental Medicine
(19)
Adolescent
(18)
Aged
(18)
Vaccination
(18)
Influenza, Human - Prevention & Control
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1)

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

Phylogenetic Origin and Virulence Genotype in Relation to Resistance to Fluoroquinolones and/or Extended-Spectrum Cephalosporins and Cephamycins among Escherichia coli Isolates from Animals and Humans

Research unit network (RUN) as a learning research system

Long-Term Risk for Readmission, Methicillin-Resistant Staphylococcus aureus (MRSA) Infection, and Death among MRSA-Colonized Veterans

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial

Strain-Relatedness of Methicillin- Resistant Staphylococcus aureus Isolates Recovered from Patients with Repeated Infection

BD Phoenix and Vitek 2 Detection of mecA-Mediated Resistance in Staphylococcus aureus with Cefoxitin

Cathelicidin Peptides Inhibit Multiply Antibiotic-Resistant Pathogens from Patients with Cystic Fibrosis

Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan

Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination

Analysis of Nontypeable Haemophilus influenzae Phase-Variable Genes During Experimental Human Nasopharyngeal Colonization

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

Phase II randomized, double-blinded comparison of a single high dose (5 × 108 TCID50 ) of modified vaccinia Ankara compared to a standard dose (1 × 108 TCID50 ) in healthy vaccinia-naïve individuals

Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical Trial

Safety and Immunological Outcomes Following Human Inoculation With Nontypeable Haemophilus influenzae

First Description of Klebsiella pneumoniae Harboring CTX-M β-Lactamases (CTX-M-14 and CTX-M-3) in Taiwan

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone® ) administered by intradermal and intramuscular route in healthy adults

Five Percent Monolaurin Vaginal Gel for the Treatment of Bacterial Vaginosis: A Randomized Placebo-Controlled Trial

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine

Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

Suchergebnisse filtern